Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
Anticancer Research|August 15, 2002
Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastasesAnne Hansen Ree, Ase Bratland, Roger A Kroes, et al.BMC Cancer|August 19, 2010
Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft modelsSiver A Moestue, Eldrid Borgan, Else M Huuse, et al.Journal of Magnetic Resonance Imaging : JMRI|February 18, 2014
In vivo ³¹P magnetic resonance spectroscopic imaging (MRSI) for metabolic profiling of human breast cancer xenograftsMorteza Esmaeili, Siver A Moestue, Bob C Hamans, et al.The Prostate|June 14, 2021
Immune checkpoint B7-H3 protein expression is associated with poor outcome and androgen receptor status in prostate cancerCaroline E Nunes-Xavier, Wanja Kildal, Andreas Kleppe, et al.Cancer Research|July 1, 2010
STAMP1 is both a proliferative and an antiapoptotic factor in prostate cancerLing Wang, Yang Jin, Yke Jildouw Arnoldussen, et al.International Journal of Cancer|June 15, 2007
Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancerTeresa Cabezón, Julio E Celis, Inge Skibshøj, et al.Cancer Medicine|October 6, 2021
Novel human melanoma brain metastasis models in athymic nude fox1nu mice: Site-specific metastasis patterns reflecting their clinical originHenrik A Svendsen, Torstein R Meling, Vigdis Nygaard, et al.Cancer Research|April 23, 2009
Species-specific in vivo engraftment of the human BL melanoma cell line results in an invasive dedifferentiated phenotype not present in xenograftsJessica Cedervall, Seema Jamil, Lina Prasmickaite, et al.Journal of Magnetic Resonance Imaging : JMRI|December 16, 2011
In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenograftsElse M Huuse, Siver A Moestue, Evita M Lindholm, et al.Molecular Oncology|March 24, 2021
Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screenAnna Barkovskaya, Craig M Goodwin, Kotryna Seip, et al.Pageof 6